Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.2%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 0.8Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information
Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCUE BIOPHARMA INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CUE - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 514K | 6.2% | $ 8.29M |
| 3/31/2025 | $ 684K | 8.56% | $ 7.99M |
| 12/31/2024 | $ 796K | 8.57% | $ 9.29M |
| 9/30/2024 | $ 1.15M | 12.08% | $ 9.53M |
| 6/30/2024 | $ 1.25M | 15.06% | $ 8.3M |
| 3/31/2024 | $ 1.27M | 18.03% | $ 7.02M |
| 12/31/2023 | $ 1.25M | 22.68% | $ 5.49M |
| 9/30/2023 | $ 1.25M | 32.64% | $ 3.82M |
| 6/30/2023 | $ 1.08M | 60.66% | $ 1.79M |
| 3/31/2023 | $ 1.06M | 244.97% | $ 432.23K |
Key Performance Insights, Last 5 Years
- CUE BIOPHARMA INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, CUE BIOPHARMA INC's average Int. Exp. % has been 24.64%.
- The median Int. Exp. % for CUE BIOPHARMA INC during this period was 7.38%
- CUE BIOPHARMA INC reached its highest Int. Exp. % over the past 5 years at 244.97%.
- The lowest Int. Exp. % recorded by CUE BIOPHARMA INC in the same timeframe 0%
CUE BIOPHARMA INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for CUE BIOPHARMA INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 3.73M ]
(=) Int. Exp. % [ 0% ] CUE - Interest Expense Margin, Last 5 years
0%
Minimum
Sep 30, 2020
244.97%
Maximum
Mar 31, 2023
24.64%
Average
7.38%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |